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In addition to being part of the classical third component of complement, 
/31c-globulin (1) has been shown to play a key role in the mechanism of immune 
adherence (2),  conglutination, immune conglutination (3),  and erythrophago- 
cytosis in vitro (4) and in vivo (5). 
Since the various functions of/3m-globtflin appear to depend upon attachment 
of the protein to the erythrocyte surface, a study was carried out with the aim 
(a) to delineate the mechanism of transfer of file-globulin from the fluid phase 
to cell membrane receptor sites, and  (b)  to evaluate quantitatively the func- 
tional significance of cell-bound/3it-globulin. This work became feasible through 
the development of an improved method of isolation of file-globulin (6)  and 
the use of a  radioactive label which permitted detection and quantitation of 
minute amounts of this protein on cell membranes and in free solution. 
Evidence will be presented indicating (a) that uptake of/3at-globulin by cells 
is effected by an enzymatic process  in which flat-globulin behaves like sub- 
strate  and  the  activated second component  of  complement like  an  enzyme 
moiety, and  (b)  that immune hemolysis and  immune adherence  necessitate 
binding of a multiplicity of fl~c-molecules per cell. 
Work in this laboratory (6,  7), and in others (8-11),  has revealed that the 
classical third component of complement consists of a number of different serum 
factors and that/3~c-globulin represents only one of the factors of this group. 
According to a recently proposed nomenclature (7, 12), these factors are called 
components three (C'3), five (C'5), six (C'6), etc., C'3 being synonymous with 
tic-globulin  and  no longer with  the  classical  third  component.  Henceforth, 
the term C'3 will be used exclusively to denote file-globulin and its hemolytic 
activity. 
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Materials and Methods 
Purified Human Complement Components.--The method of isolation of the  fourth com- 
ponent of complement (C'4), or ~l~.-globulin, was described previously  (13). The preparations 
of C'4 used in this study were homogeneous upon starch gel and immunoelectrophoresis. As a 
further check of molecular homogeneity, samples of each batch were tested  for susceptibility 
to the action of C'I esterase (kindly supplied by Dr.  Irwin Lepow,  Cleveland). In each in- 
stance,  the protein underwent complete  conversion to  the  characteristic inactive reaction 
products which are distinguished from the native protein by a  different mobility on starch 
gel electrophoresis (14). 
Cr3 was isolated according to a  recently published method (6)  by which the protein can 
be obtained free of C~5, C'6, and ~m-globulin. The preparations used were homogeneous by 
the criteria of starch gel electrophoresis and immunoelectrophoresis, all of  the protein being 
present in the electrophoretically slow, hemolytically active form. 
The second component of complement (C'2) was obtained according to a  method to be 
published in full elsewhere (15 b). For the purpose of this study it was thought sufficient to 
use preparations that were 5000- to 7000-fold purified, as compared to serum and that con- 
tained approximately 25 to 30% C'2 in terms of total protein. These preparations were free 
of other complement components and were contaminated primarily with ~lA-globulin. They 
were  obtained by chromatography on carboxymethyl cellulose followed by electrophoresis 
on Pevikon blocks. Throughout the procedure of isolation, phosphate buffer pH 6.0,  T/2  --- 
0.05, was used which contained 0.005 ~  EDTA. 
To enhance CP2 activity, some of the preparations were treated with iodoacetamide (0.05  ~¢) 
at pH 6 and at a maximalprotein concentrationof 100/~g/ml, as described previously (15 a, 16). 
This resulted in a 7- to 10-fold increase in apparent Cr2 hemolytic activity. 
Labeling of C~3 and C4 with Radioactive lodine.--Many different batches of both proteins 
were  successfully labeled with iodine-131  (I  TM)  or iodine-125  (1125) according to  a  method 
described by McConahey and Dixon (17). 500/zc of either I TM or 1  l*s were addedin carrier-free 
form without preservatives or reducing substances to 2 mg of protein in 4 ml ice cold veronal- 
sodium chloride bufferpH 7.3. While the protein-iodine mixture was stirred, 100/zg of chlor- 
amine T(200/zg/ml solution in distilled water) was added and allowed to react for 5 min. The 
oxidizing agent was then neutralized by the addition of 100/zg sodium meta  bisuifite. To 
remove unbound iodine, the iodinated protein was dialyzed for 24 hr against 3  X  10 liters 
of veronal--sodium chloride buffer. Iodine uptake varied between 60 and 80o'/0, the specific 
radioactivity of labeled C~4 between 3  X  104 and 4  X  lif  t cP~//~g, and the specific radio- 
activity of labeled C~3 between 5 X  104 and 7 )< 104 cP~r//zg. The procedure of labeling had 
no effect on the hemolytic activity of C~3 and in most instances no effect on Cr4. For unknown 
reasons, the hemolytic activity of two batches of C~4 was reduced to one-third of the original 
value after iodination. These batches were not used for this study. For experiments in which 
C~3 was used in high concentrations, the specific radioactivity of this protein was reduced 
to 3 to 10 X  10  a cP~/#g by mixing labeled with unlabeled C~3. 
Preparation of Sheep Erythrocyte-Complement Complexes with Radioactively Labeled and 
Unlabeled Complement Components.--EAC'la,4, the complex consisting of sheep erythrocytes 
(E), rabbit antibody to sheep erythrocytes (A), the activated first component of complement 
(Cqa)  and  C'4,  was prepared in the following way.  EA was incubated with the chroma- 
tographically separated subcomponents of the first component, Cqq,  Cqr and C'ls, as de- 
scribed by Lepow et at. (18). This resulted in formation of the complex EAC'la. Since C'lr 
was contaminated with C~4, this fraction was treated before use with 0.02 ~  hydrazine at 
37°C for 45 rain. While C~4 was thus inactivated, C'lr activity remained unimpaired. 10 ml 
of a 2.5% suspension of EACqa was then incubated with 4.5 to 80/zg of purified C'4 at 37°C 
for 30 min. The ceils were washed twice before use. H.  J.  MOI,  LER-EBERHARD~  A.  P.  DALMASSO~ M.  A.  CALCOTT  3~ 
When EAC'la,4 was made using I m- or IX2~-labeled C'4, the procedure was slightly modi- 
fied. Human serum albumin (Behringwerke "reinst") was added in substance to the solution of 
labeled C'4 to yield an albumin concentration of 2%. The labeled protein was thereby pre- 
vented from forming small amounts of precipitate in the course of being pipetted.  Even a 
minute amount of radioactive precipitate in the reaction mixture constitutes a large source of 
error causing falsely high values for cellular Cr4-uptake. The albumin-Ct4 solution was there- 
fore centrifuged before use at 1300 X  g for 20 rain. 
To minimize nonspecific adsorption of radioactively labeled Ct4 to the erythrocyte surface, 
the cells were incubated, after sensitization with antibody, with KBr-treated serum. To 20 
ml of a  2.5% suspension of EA containing 0.01 M EDTA, 0.5 ml of KBr-treated serum was 
added and the mixture left at 4°C for 1 hr, whereupon the cells were washed twice, once in 
0.01  M EDTA  containing veronal buffer and once in Ca  +4 and  Mg  ++ containing veronal 
buffer. As will be pointed out below, KBr-treated serum contains C'3 and C'4 in hemolytically 
inactive form. This measure reduced nonspecific cellular adsorption of radioactive C'4 and 
C'3 from more than 14 to less than 1%. 
Table I lists the number of C'4 molecules taken up per cell as a function of C'4 input into 
the reaction mixture. The total reaction volume was 4  ml, the number of cells 9.2  ×  10  s, 
and the time at 32°C 30 rain. Specific uptake was ascertained as described below. 
In some instances, EACqa,4 cells were obtained by decay of EACqa,4,2a  cells at 37°C 
for 90 rain. 
EAC'la,4,2a  ceils were  prepared  by incubating EACtla,4  cells at  32°C  for  a  prede- 
termined period of time (tm~=) with an excess of purified C~2 or with iodoaeetamide-treated 
C'2. The half-life of this complex at 32°C was 10 rain when untreated C'2 was used and ap- 
proximately 150 rain when CP2 was first treated with iodoacetamide (15a, 16). 
Alternatively, EAC'la,4,2a cells were prepared with whole human serum in the presence 
of phloridzin. 30 ml of a  2.5% suspension of EA was mixed at 37°C with a  solution of 320 
mg phloridzin in 30 ml of isotonic veronal buffer. Phloridzin was dissolved by miring the 
temperature briefly to  70°C.  2 ml of human serum was then added to the phloridzin con- 
taiuing cell suspension. After exactly 1.5 rain at 37°C, the mixture was poured into 140 ml of 
ice cold isotonic veronal buffer and centrifuged at 0°C. The cells were washed once before use. 
Tested with 1:20 dilution of human serum in the presence of 0.01 ~ EDTA, these cells usually 
lysed completely within 10 to 15 rain. They were free of significant amounts of C'3, as evi- 
denced by negative immune adherence and negative agglutination with an antiserum to C'3. 
EAC'la,4,2a,3.--This  complex was made by treating EACtla,4,2a  cells with purified 
C'3 at 32°C for 5 to 30 rain in veronal buffer pH 7.3.  Since 90 to 95%  of the C'3  input is 
found after  the reaction in  the fluid phase as hemolytically inactive,  converted  C'3,  the 
input should exceed the desired uptake 10- to 20-fold. Formation of this intermediate complex 
was tested with a 1:20 dilution of KBr-treated human serum in the presence of 0.01 x¢ EDTA. 
When radioactively labeled C'3 was used, the same measures were employed that were 
described above for the use of radioactively labeled C'4. 
Other erythrocyte-complement complexes utilized in this study were EC'4, ECt4,2a, and 
EC'4,2a,A. Technical details of the formation of EC'4 were described previously (14). The 
complex ECI4,2a was made by incubating 2 ml of a  7.5% suspension of EC~4 cells with an 
excess of iodoacetamide-treated, purified C'2 and 0.25 units of CJ1 esterase for 30 to 40 rain 
at 32°C. The total reaction volume was 2.5 ml. After incubation the cells were washed twice 
with ice cold verona] buffer. In one experiment, EC'4,2a cells were sensitized with 8 units of 
anti-sheep erythrocyte antibody to yield EC~4,2a,A cells.  Source of the antibody was a  19S 
fraction which was isolated from a rabbit antiserum by sucrose density gradient ultracentrif- 
ugation in phosphate buffer pH 7, T/2  =  0.1. 
Quantitation of C'3- and C~4-Uptake by Erythrocytes.--For quantitation of cellular uptake, 
radioactively labeled components were used.  If uptake of both C'3 and C~4 was measured 36  I~MU~CE  HEMOLYSIS 
in the same experiment, a  differential radioactive label was employed.  All determinations 
of Cr3 - or  Ct4-uptake  were performed in two  different sets of reaction mixtures,  one con- 
taining optimal amounts of Ca  -~" and Mg  ++ and the other 0.01 ~ EDTA. The latter set yielded 
values for nonspecific attachment due to adsorption and not due to the action of the comple- 
ment system. To obtain the value for specific uptake of Cr3 or CP4, the value for uptake  ob- 
served in the presence of EDTA was subtracted from that measured when Ca  ++ and Mg  ++ 
were present. For computing the number of molecules per cell, a molecular weight of 300,000 
was assumed for both CP3 and Cr4, since their s rates are 9.5S and 10.0S,  respectively. The 
s rates were essentially unchanged after dissociation of the two components from complement- 
treated erythrocytes (19). The number of C~3 molecules per C'4,2a site was calculated by 
determining the molar ratio of Cr3 to C~4 on the cell surface. This method yields a minimal 
estimate, since it is not known whether all C'4 sites were in association with an activated 
Ct2 molecule while the interaction between the cells and Cr3 occurred. 
Quantltatlon  of Converted Cr3 in the Fluid Phase.--This again was done using radioactively 
labeled C'3. After the reaction was stopped by centrifugation of the reaction mixtures at 0°C, 
suitable samples of the cell-free supernatants were analyzed by immunoelectrophoresis. Mter 
2.5 hr of electrophoresis at 6 v/cm, the patterns were developed with a  specific antiserum to 
TABLE  I 
Relation  Between Input of C'4 1125 and Its Specific,  Cdlular  Uptake 
Input  Specific uptake  Molecules/cell 
ug  ~g  % 
0.92  0.07  7.7  154 
2.75  0.21  7.6  453 
7.35  0.47  6.4  1020 
Reaction volume, 4  ml; number of ceils,  9.2  X  10s;  time at 32°C, 30 rain. 
C'3. 15 hours later the gel was cut into segments such that the C'3- (or ~m) precipitin line and 
the C~3i  -  (or ~IG) fine (7,  26) were located in different segments. The radioactivity in each 
segment was then counted and the counts obtained on the C'3i-segment were expressed in 
per cent of total number of counts (C'3 plus C'3i). Controls included the original C'3 material 
that had not been reacted with cells and C~3 that had been incubated with cells which, how- 
ever, did not contain activated C'2. 
lmmune  Adkerenee.--The  method  of  Nishioka  and  Linscott  (2)  was  adopted.  The 
EACqa,4,2a,3  complex  was  assembled  stepwise  as  described  above  using  radioactively 
labeled C~3. Immediately after the cells were prepared, one portion was used for the immune 
adherence test and another portion was set aside for quantitation of bound radioactive C'3. 
Incorporation  of Radioactively  Labeled C'3 and  C~4 into  Human Serum.--One part of satu- 
rated aqueous solution of KBr was added to one part of human serum and the mixture was 
kept at 4°C overnight. KBr was then removed by thorough dialysis against phosphate-buffered 
saline. As will be reported elsewhere (20), this treatment resulted in selective inactivation of 
CI3 and Ct4 and concomitant physicochemical changes of these two proteins. In addition Ct5 
activity was reduced by approximately 30%. Hemolytic activity is virtually restored by addi- 
tion of purified ct3 and Ct4. For several experiments, KBr-treated serum wasreconsfituted by 
addition of 30 to 580 ~g of radioactively labeled Ct3 and of 10 to 90 #g of radioactively labeled 
Ct4. The normal serum concentration of C~3 and C~4 is estimated  to be approximately 500 
~g/ml and 40 to 60 tzg/ml, respectively. 
Quantitation  of Hemolysis  as a Function  of C~3 Uptake.--The  reaction mixtures consisted II.  J.  MOLLER-EBERHARD,  A.  P.  DALI~IASSO, M.  A.  CALCOTT  37 
of 8 to 10  X  l0  s EA and 1:40 KBr-treated serum which was reconstituted with respect to 
Ct3 and C'4. Either C'3 alone or C'3 and Ct4 were labeled with radioactive iodine. The total 
reaction volume was 4 ml and the reaction time at 32°C varied between 18 and 60 min. Con- 
trols contained 0.01 ~ EDTA instead of optimal amounts of Ca  ++ and Mg++. The reaction was 
terminated by transfer oi the reaction tubes to a 0°C alcohol bath. Immediately thereafter, 1 
ml aliquots were withdrawn for determination of the degree of hemolysis. The remaining 3 
ml were diluted with 27 ml of ice cold veronal buffer and subjected to centrifugation at 25,000 
RPM. and I°C for 30 rain in a  Spinco L2 ultracentrifuge using a No. 30 rotor. The sediments 
consisting of unlysed cells and cell ghosts were washed twice by resuspension in 30 ml veronal 
buffer and ultracentrifugation before their radioactivity was determined. In some experiments 
highly purified CI5 was added in excess to the reaction mixture. 
Other  Methods.--Sucrose  density gradient  ultracentrifugation was  performed according 
to Kunkel (21) and immunoelectrophoresis  according to Scheidegger (22). 
FIG.  1.  Immunoelectrophoretic demonstration of  the conversion of highly purified  Cr3 
to CI3i by EAC'la,4,2a cells. Upper pattern,  C'3 after incubation at 37°C for 15  min with 
EAC'la,4,2a. Lower pattern,  Ct3 after incubation under the same condition with EACrla,4 
Anode was at the right; pattern was developed with rabbit anti-C'3. 
RESULTS 
The  Immediate  Reaction  Product  of C'3.--It  was  previously reported  that 
CP3 undergoes changes in physicochemical and immunologic properties when 
participating  in  the  interaction  of  complement  with  antigen-antibody  com- 
plexes. These observations were made on C'3 in whole human (23)  and mouse 
(24) serum, and in guinea pig euglobulin (25). The presence of a large number 
of other serum constituents hindered thorough analysis of the reaction product 
and did not allow precise definition of the complement factors which govern 
the C'3 reaction step. 
The behavior of CP3 was,  therefore, studied in reaction mixtures consisting 
only of highly purified Ct3  and of defined erythrocyte-complement complexes. 
Fig.  1 shows an immunoelectrophoretic analysis of C'3 after a  short period of 
incubation at  37°C  with EAC~la,4  and  EACqa,4,2a.  The protein was  con- 
verted to a more rapidly migrating form by cells containing activated C~2 on 
their  surface  (EACqa,4,2a),  but  not  by  cells  lacking  this  component 
(EAC'la,4). 
Ultracentrifugal  analysis  in  a  sucrose  density  gradient  revealed  that  the 38  IMMUNE  HEMOLYSIS 
sedimentation velocity of converted C'3 is very similar to, although not identical 
with,  that of native C'3 (Fig. 2). In four different experiments it was found to 
be approximately 9S,  the s  rates of native C'3 and "aged" C'3 (flEe-globulin) 
being  9.5S  and  6.9S,  respectively  (1).  Several  ultracentrifugal  experiments 
were performed with  Ilal-labeled C~3  to  facilitate  detection  of low molecular 
weight split products which might arise in the process of conversion.  As seen 
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FIG. 2.  Comparative ultracentrifugal analysis of C'3 and C'3i. Upper pattern,  C'3 1131. 
Lower pattern,  C'3 ][1,1 after complete conversion to C'3i by EAC'la,4,2a. Both samples 
were centrifuged for 20 hr at 35,000 RPM. in a 10 to 40% sucrose density gradient. 
in Fig.  2,  a slowly sedimenting,  radioactively labeled component could not be 
detected after conversion. 
Freshly converted Ct3 was tested for hemolytic activity and compared with 
identical amounts of the native protein. The results, which are listed in Table 
II, show that converted C'3 is totally inactive. In the following it will, therefore, 
be referred  to  as C'3i instead  of  "~m", an immunoelectrophoretic term used 
previously (7,  26). 
Ouchterlony plate and immunoelectrophoretic analysis of Ct3i showed it to 
be antigenically deficient when compared with native C'3. The precipitin line 
of  the  latter  spurred  over that  of  Ct3i.  In  this  respect,  C~3i resembles ~IA- 
globulin,  the  previously described  product  of  aging.  However,  the  s-rate  of H.  J'.  MULLER-EBERHARD,  A.  P.  DALMASSO,  M.  A.  CALCOTT  39 
C~3i indicates that it is distinct from fl~-globulin and that conversion of C'3 
to C~3i involves a relatively subtle change of the molecule, the chemical nature 
of which is presently being investigated. 
TABLE  II 
Hemolytic Activity of Native and of Converted C'3 
Amount of protein 
ug 
1.8 
3.6 
9.0 
18.0 
C'3 hemolytic activity* (per cent lysis) 
Native protein 
18 
34.5 
56.5 
71.0 
Converted protein (C'3i) 
*  Assay: 2  X  l0  s EAC'la, 4,  2a; KBr-treated serum, 1:40; total reaction volume, 1 ml; 
containing 0.01 M EDTA; time at 32°C, 15 rain. 
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FIG.  3.  Uptake of C'3 I I~5 by EAC'la,4 cells as a  function of the amount of C'2 in the 
reaction mixture (reaction time, 3 rain; temperature, 34°C). 
The Complement Factor Which Governs the C~3 Reaction  Step.--The  C~3 re- 
action step of human complement involves both conversion of C'3 to C'3i and 
attachment of the protein to antigen-antibody complexes or cell membranes 
(7). As demonstrated in Fig. 1, conversion requires the presence of Ct2a, a fact 
which was also recognized by Pondman and Peetoom (27).  Similarly, uptake 
of Ct3 by cells was found to be dependent upon C~2a. This is illustrated in Fig. 40  I~lUm~  HEMOLYSIS 
3, which depicts the results of an experiment in which the initial concentration 
of Ct3 was large as compared to the amounts of C~2 used. Under these condi- 
tions, a linear relationship was observed between uptake of C~3 by EAC~la,4 
cells and the concentration of C~2 in the reaction mixture. Since C~2 reacts with 
TABLE III 
Effect of Cell Concentration Upon the Rdation Behveen C'3 Uptake and C'3 Conversion 
C'3 I m 
~eactlon  volnme 
Input  Conversion  Uptake 
0.2 
0.4 
0.8 
154 
328 
656 
Uptake 
~g 
21 
35 
45 
~g 
136 
266 
392 
conversion 
t/6.5 
1/7.6 
1/8.7 
Number of EAC'la, 4, 2a, 8.6 X  10s; initial C'3 concentration, 820 #g/ml; time at 32°C, 
30 rain. 
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FIG.  4.  Kinetic analysis of uptake of CI3 I ~s by EAClla,4,2a cells. The cell concentra- 
tion was 25%; the initial C'3 concentration, 1.2 X  106 molecules per cell; and the temperature, 
37°C. EAC'la,4 cells were used as control. 
EAC'la,4 to yield EACqa, 4,2a, it follows that the extent of C'3 attachment 
is determined by the number of available Ct4,2a sites per cell. 
The relation between uptake  and conversion was  studied by quantitafing 
both reactions simultaneously. This was done in a set of reaction mixtures which 
were identical with respect to the absolute number of cells and the initial C'3 
concentration, but which differed with respect to reaction volume and, hence, 
cell concentration. The results are listed in Table HI. Most of the C'3 which H. ~. MOLLER-EBERHARD~ A. P. DALMASS% M. A. CALCOTT  41 
was turned-over by the EAC'la, 4, 2a cells was found as C'3i in the fluid phase 
and only 10 to 14 % was bound to the cells. While the ratio of uptake to con- 
version varied somewhat with the size of the reaction volume, uptake remained 
small as compared to conversion. 
C'3 Uptake as a Function of Time, pH, Temperature, and C'3 Concentration.- 
To characterize  further C'3 binding,  the reaction was studied under a variety 
of different experimental conditions. The velocity of the reaction was estimated 
in a number of kinetic experiments in which EAC'la,4, 2a cells were incubated 
with C'3 11.~ at 37°C and pH 7.3 for certain intervals of time. In one of these 
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FIG.  5.  Uptake of C'3 I ~5 by EAC'la,4,2a cells as a  function of pH. The reaction was 
allowed to proceed for 5 rain at 37°C. 
experiments,  the cell concentration was chosen to be 25 % and the initial C"3 
concentration 1.2 X  106  molecules per  cell. As  seen  in  Fig.  4,  the  reaction 
started without lag and proceeded rapidly resulting in the binding of 1.35 X  105 
C'3 molecules per cell in the first minute. EACtla,4 cells subjected to the same 
conditions did not bind significant amounts of C'3. 
The effect of pH on C'3 binding is illustrated in Fig. S. Isotonic phosphate 
buffers were used and the pH was varied between 5.6 and 7.9. The pH optimum 
was found between pH 6 and pH 7. 
The effect of temperature on C'3 binding is depicted in Fig. 6. The reaction 
was carried out at pH 7.3 in isotonic NaC1 veronal buffer, i.e., under conditions 
conventionally employed for the quanfitafion of hemolytic complement.  The 
reaction proceeded  maximally at a  temperature of approximately 32°C and 
stopped at 0°C. 
The influence of the initial C'3 concentration on the rate of binding was 42  m~VNE  m~oLYsls 
investigated next and the result is shown in Fig. 7. The C'3 concentration was 
varied between 0.6 ×  104 and 2 ×  10 ~ molecules per cell. In this concentration 
range the reaction proceeded according to first order kinetics. The kinetics of 
the C'3 binding reaction as well as its temperature- and pH-dependence suggest 
that it is enzymatic in nature. 
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FIG. 6.  Uptake of C'3 1125 by EAC'la,4,2a cells at various temperatures. The reaction 
time was 4 rain, the pit 7.3. EAC'la,4 cells were used as control. 
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FIG. 7.  Rate of uptake of C'3 I ~  by EAC'la,4,2a cells as a function  of the initial C'3 
concentration. The reaction was carried out at 37°C with 8 X  10  s cells in 1.5 ml total reaction 
volume. H. J.  MUI,  LER-EBERHARD,  A.  P.  DALMASS0,  M.  A.  CALCOTT  43 
Inhibition of C~3 Uptake.--In view of the probable enzymatic nature of the 
C~3 binding reaction,  several amino acid derivatives and other agents were 
tested  for  inhibitory  activity.  The  following  substances  lacked  inhibitory 
activity at the concentration tested; p-tosyl-L-arginine methyl ester (1.3 X  10  -2 
~),  benzoyl-glycine  methyl  ester  (1.3 X  10-2~),  IAysine  methyl  ester 
(1.3 X  10  -2 ra), ,-amino-N-caproic acid (1.3 X  10  -2 ~t), diisopropylfluorophos- 
phate (10  --4 ~r), iodoacetamide (2.7 X  10  -2 ~r). By contrast, phloridzin exerted 
a  marked inhibitory effect (Table  IV).  This substance had previously been 
pointed  out  as  a  complement inhibitor,  interfering with  the  classical  third 
component (28). Since phloridzin did not inhibit C'3 conversion, it is improbable 
that it interfered with C'2a activity. Instead, it probably exerted its effect by 
blocking C~3 receptor sites on the cell surface. 
TABLE IV 
Effect of Ptdoridzin on Uptake o/C'3 I lm by EAC'la, 4, 2a 
Phloridzin  C'3 I  TM uptake  Inhibition of uptake 
mg/ral 
0.000 
O. 125 
o. 250 
o. 500 
1.000 
t~g 
3.6 
2.65 
1.92 
1.12 
1.02 
% 
0 
27 
47 
69 
72 
Conditions: 109 EAC'la, 4, 2a; 50/zg C'3 1131; volume, 4 ml; 5 rain at 32°C. 
C'3 Binding Capacity of a Single C~4,2a-Site on the Cell Surface.--If  specific 
binding of CP3 was simply due to adsorption, only one or a very few molecules 
of the protein would be expected to be bound by a single C~4,2a site. If, how- 
ever, C~4,2a functioned as an enzyme catalyzing uptake of C~3 by cell mem- 
brane receptors, the number of molecules bound per site might be much larger. 
To distinguish between the two possibilities, the C~3-C~4 ratio was determined 
for cells in the state EACqa, 4,2a, 3. To this end, EACqa, 4 cells were prepared 
which contained a known number of C~4 molecules per cell using C~4-I  m. They 
were then incubated with C'3-I  ~5 in the presence of an excess of iodoacetamide- 
treated C~2. Fig. 8 shows the molecular ratio of cell-bound C~3 and Cr4 as a 
function of the initial Ct3 concentration in the reaction mixture. It is obvious 
that a single C'4, 2a site can be instrumental in the binding of many, i.e., several 
hundred C'3 molecules. 
The Nature of the C'3 Receptor.--The  fact that as many as several hundred 
C'3 molecules can become cell-bound through the action of a single Cr4,2a-site, 
precludes the possibility that the Ct4,2a site itself functions as C'3 acceptor. 
Such  a  large  number  of macromolecules could not  attach  themselves  to  a 44  IMMUNE  HEMOLYSIS 
bimolecular complex roughly equal in size to one C'3 molecule.  This leaves as 
probable sites of attachment  the antibody molecules coating the cell surface 
and the cell membrane itself; C'I can be ruled out because it can be detached 
from EAC'la,4,2a cells without impairing their reactivity with C'3 (29). 
To determine whether antibody is essential for C'3 binding to cells, erythro- 
cyte-C'4,2a complexes were prepared which were entirely devoid of antibody 
(30 b). As shown in Table V, the EC'4,2a cells were as capable of binding C'3 
as cells that contained, in addition to C'4,2a, 8 hemolysin units of 19S rabbit 
300 - 
b 
"6  250- 
"5 
200" 
tO 
~  150 
to 
b 
g 
3  too 
.~"  so 
16o  26o  soo  46o  sGo 
,~g of C'3  1125 in  Reaction  Mixture 
FIc.  8.  C'3 binding capacity of a single C'4,2a-site on EACqa,4,2a cells determined for 
various initial concentrations of C'3 in the reaction mixture. The reaction was performed at 
32°C for 40 rain using 4.9 X  l0  s cells in 3 ml total reaction volume, each cell carrying on its 
surface an average of  138 C'4 molecules. C'2 was used in iodoacetamide-treated form and 
C'3 was labeled with I LeS. 
anti-sheep erythrocyte antibody (EC'4,2a, A). It is,  therefore, concluded that 
binding of Cr3 occurs directly to cell membrane constituents and that antibody 
plays no essential  role  in this reaction.  The above observation does not pre- 
clude, however, the possible occurrence of C'3-anfibody complexes.  Attention 
is drawn to the fact,  also shown in Table V,  that  C'3 which was bound by 
EC'4,2a in the absence of antibody was potentially cytolytic. Together with 
other terminal complement factors it caused lysis of the cells by which it was 
carried. 
It was shown previously (14) that C'4 can be attached to E by the action of 
C'I esterase present in the fluid phase. It appeared possible that in an analogous 
fashion C'3 might be bound to E, EA, or EC'4 by fluid phase C'4,2a complex. 
This,  however, was not observed (Table V). The possible significance  of this H.  J.  M  OLLER-EBEP.HARD~ A.  P.  DALMASSO~ M.  A.  CALCOTT  45 
observation will be discussed below. Preparation and properties of the C'4,2a 
complex in cell-free solution will be described elsewhere (30 b). 
The  Functional  Significance  of  Cell-Bound  C'3.--As  demonstrated  above, 
EAC'la,4,2a cells, due to the action of their C'4,2a sites, have the capacity to 
bind a large number of C'3 molecules. The question arose, therefore, whether 
TABLE V 
C'3 ~1at Uptake by Cells in the Presence of Call-Bound or of Fluid Phase C'4, 2a Complex 
Cell complex*  Fluid phase  C'3 pn uptake (per  Cell-bound  C'8 activ- 
cent Input)  ity (per cent lysls) 
E 
E 
EA 
EA 
EC'4 
EC'4 
EC'4, 2a 
EC'4, 2a, A 
C'4, 2a 
C'4, 2a 
C'4, 2a 
3.8 
3.8 
3.6 
3.4 
3.8 
3.8 
22.0 
21.0 
0 
0 
0 
0 
0 
0 
43 
42.5 
* Conditions: 5.7 X l0  s cells, 50/zg C'3/131, 0.7 r£11 reaction volume, 10 rain at 32°C. 
TABLE VI 
Immune Adherence Capacity of EAC'la, 4, 2a, 3 in Rdation to the Number of C'3 Molecules 
per Cell 
C'3 (molecules/cell) 
170 
510 
910 
2830 
Intensity of reaction (concenration  of cell lysate) 
2.5%  0.5% 
0 
0 
½ 
1 
3 
0.1% 
0 
0 
0 
½ 
1 
multimolecular binding of C'3 is a prerequisite for the manifestations of com- 
plement-cell interaction,  such as immune adherence and immune cytolysis. 
Sheep  erythrocytes  containing  on  their  surface  known  numbers  of  C'3 
molecules  were  tested  for  their  immune  adherence  capacity.  Cells  with  an 
average of 510 or more bound C'3 molecules gave a positive reaction, while ceils 
containing 170 bound C'3 molecules were negative, even when tested at a  cell 
concentration of 2.5 %  (Table VI). Thus, the critical number of molecules per 
cell which led to a  detectable reaction was somewhere between  170 and 510, 
while  a  reaction  of maximal intensity  required  several  thousand  bound  C'3 
molecules per cell. 
The requirement of C'3 in immune hemolysis was investigated next and the 46  ~m~  H~MOI,¥SIS 
data are summarized in Table VII. In this experiment the degree of hemolysis 
achieved was compared with the amount of Ct3 incorporated into the reaction 
TABLE VII 
Rdation Between Degree  of Hemolysis, C'3 Input and C'3 Uptake by Cell Membrane 
C'3 Input 
Pg 
0.00 
1.45 
7.25 
14.50 
~g 
0.00 
0.35 
1.47 
2.57 
(Molecules/Cell) 
0 
760 
3200 
5600 
C'3 Uptake 
Hemolysis 
% 
1.0 
15.6 
46.0 
64.0 
Number of EA, 9.2 X  10s; KBr-treated  serum, 1:40;  C'4,  7.35/zg; volume, 4 ml; time 
at 32°C, 30 rain. 
60- 
50  -  I~cules/cell 
C~ 
%40- 
x 
30- 
5 
"E  20. 
$ 
°"  I0"  ~ 
Uptoke; Number of C'3 Molecules per Molecule of C'4 
FIG. 9.  Relation between hemolysis and C~3 binding to the ceils; shown for three different 
levels of C~4 multiplicity. C'3 uptake is expressed in terms of minimal number of C~3 mole- 
cules bound per C~4,2a site. The reaction was performed with radioactively labeled Ct3 and 
C'4 and with KBr-treated serum (1:40) in a total volume of 4 ml, for 30 min at 32°C. 
mixture  and with  the  number of  C~3  molecules bound in the  course  of  the 
hemolytic reaction. 
KBr-treated  serum was  used  as  a  source  of  all  complement components, 
except  C'3  and  C~4;  these  two  components were  supplied  in  radioactively H.  J.  MIJI,LER-EBE~,  A.  P.  DALMASSO,  M~.  A.  CALCOTT  47 
labeled form. While the amount of C'3 was varied, all reaction mixtures received 
an equal amount of C'4 which provided 1020 bound molecules per cell.  Iodo- 
acetamide-treated,  purified C'2  was  added  to  assure  an excess of this  com- 
ponent in all samples. The values of C'3 uptake recorded in Table VII represent 
specific binding; nonspecific binding was less than 1%. 
Hemolysis increased with the amount of C'3 input and with the number of 
cell-bound C'3 molecules. At 64% lysis the average number of C'3 molecules 
bound per cell was 5600. Addition of an excess of purified C'5 (6) resulted in a 
reduction  of  this  figure  by  approximately  30 %.  Complete  proportionality 
_  I000 
0 
800' 
0 
~600- 
b 
~4oo-  o 
E 
/z O/o 
Number of Bound C'3 Molecules per Molecule of Bound C'4 
FIO.  10.  Reciprocal relation between the amounts of cell-bound C'3 and C'4 in hemolysis; 
shown for 12, 18, and 23% lysis of 9.2 X  10  s cells. The reaction was carried out at 32°C for 
40 mill using radioactively labeled C'3 and C% KBr-treated serum (1:40) and iodoacetamide- 
treated C'2 in a total volume of 4 ml. 
between lysis and C'3 binding was revealed when the hemolysis data listed in 
Table VII were expressed according to Mayer (12,  31) in terms of "average 
number of hits per cell". It is inferred from these observations that the molec- 
ular multiplicity occurring at the C'3 step of the complement reaction is func- 
tionally relevant with respect to immune adherence and the cytolytic effect of 
complement. 
Reciprocal Relationship  Between C'3 and C'4 Requirement in Immune Hemol- 
ysis.--The final question pursued in this study was whether a given degree of 
hemolysis corresponds to a  characteristic number of bound C'3 molecules per 
cell. It was found that this number was variable in that it was inversely propor- 
tional to the number of cell-bound C'4,2a sites. For example, 23 % hemolysis 
was achieved with  1333 bound C'3 molecules and  1020  bound C'4 molecules 48  ~'MUNE  13E~OLYSIS 
per cell.  At the same level of lysis, 5500  bound C~3 molecules per cell were 
required when these cells contained only 154 bound C~4 molecules each. 
Fig. 9 shows the quantitative relation between hemolysis and the ratio of 
bound C~3 and C~4. Three different cell batches were used, each differing in the 
number of bound C~4 molecules per cell. Again, this experiment was performed 
in the presence of KBr-treated serum and of an excess of iodoacetamide-treated 
Ct2. To achieve a  certain degree of hemolysis, only a few C'3 molecules were 
required per Cr4, 2a site if the Cr4 multiplicity was high. However, if this was 
low, many more C'3 molecules were necessary. The reciprocal relation between 
C~3 and C~4 in hemolysis is more clearly demonstrated in Fig. 10, where it is 
shown for three different degrees of lysis, namely 12, 18, and 23 %. 
DISCUSSION 
The experiments described above are part of a  comprehensive study which 
aims at the elucidation of the entire complement reaction mechanism. Previous 
reports from this laboratory dealt with the mechanism of action of C/4 (14) 
and with the formation of functionally significant complexes between C~5 and 
C~6 (6, 32),  and Ct2 and C~4 (30 a). The present work was focused entirely on 
the reaction mechanism of C'3 in complement-cell interaction. 
Three  questions  were  primarily  pursued:  (a)  Which  is  the  complement 
component that governs the C'3 reaction step? (b) How is Ct3 bound to cells? 
(c) To what extent does bound C~3 participate in the cytolytic reaction? Two 
major technical requirements had to be fulfilled to enable this investigation: 
(a) Detection and estimation of the hemolytic activity of C'3 and; (b) detection 
of C'3 by a method not based upon its hemolytic activity but upon some other 
property of the component. The latter method was needed to follow the fate of 
Ct3 throughout the hemolytic reaction beyond the point where it can be recog- 
nized by its activity. It also was to serve for quantitation of Ct3 on a molecular 
basis and thus to permit establishment of the relation between dose and activity. 
Serum treated with KBr became a convenient tool for assaying Ct3 activity. 
As will be shown elsewhere (20),  KBr inactivates Cr3  and C~4 while leaving 
intact all other complement factors. To assay cell-bound C~3 one may proceed 
in a fashion which is analogous to that used for the determination of cell-bound 
C'2a. EACqa, 4,2a cells are assayed by lysis in the presence of EDTA-serum 
(33). Similarly, EACqa,4,2a, 3 cells can be determined by lysis in the presence 
of EDTA-serum  that was previously treated with KBr.  KBr-treated serum 
also proved useful for preparing complement in which C~3 and Ct4 were replaced 
by known amounts of their radioactively labeled counterparts. 
Detection of C'3 and also of C~4 without resort to their hemolytic activity 
was afforded by means of a radioactive label. A technique was employed utilizing 
I m  and I  ~"1 in carrier-free form thus minimizing the risk of loss of biologic 
activity due to iodination. The hemolytic activity of all labeled preparations 11. J. MOLLER-EBERB.ARD,  A. P. DALMASSO,  M. A. CALCOTT  49 
employed in  this  study was  carefully compared  with  that  of  the  original 
material; in no instance did labeling result in loss of activity. Iodination was 
carried out such that it resulted in an average specific radioactivity of approxi- 
mately 50,000 cPM//zg. This afforded the detection of as little as 0.002 #g of 
C'3 or C'4. 
The possibility existed that the C'3 reaction step was governed not only by 
C~2a, but also by one of the later complement  components,  e.g., Cr5  or C'6. 
Some evidence, possibly in favor of such a mechanism,  had been obtained by 
Linscott and Cochrane  (25) who worked with guinea pig euglobulin fractions 
as a source of CP3. To obtain an unequivocal answer, the use of highly purified 
C'3 was imperative.  C'3 devoid of detectable contaminants and, in particular, 
free of C~5 and C'6 was obtained according to an improved method of isolation 
which was published  recently (6). Utilizing this material it became apparent 
that both reactions,  binding of C~3 to ceils and conversion of Ct3 to C~3i are 
effected solely by cell-bound C~2a. 
It should be mentioned at this point that C'2a occurs in the form of a protein- 
protein complex with C'4. According to unpublished  observations made in this 
laboratory (30 b), formation of the C'4,2a complex requires the catalytic action 
of C'1 esterase. C~2 cannot be converted to its hemolytically  active form, C'2a, 
unless it becomes linked to C'4. Thus, "C'2a" always implies that this com- 
ponent is present in form of the activated C'4,2a complex. It is this complex 
that is actually responsible for the conversion and binding of C~3. 
Innumerable observations  indicate that for human C'3 there exists an inti- 
mate relation between  binding to cells and  conversion.  Binding was  never 
observed to occur without the appearance  of the conversion product, C'3i, in 
the fluid phase. On the other hand, conversion was found to proceed freely in 
the absence of binding. This was shown by treating serum with C'1 esterase, as 
was done by Pondman (27), or by reacting purified  C'3 with isolated C~4,2a 
complex in cell-free solution (30 a and 30 b). It would seem probable, therefore, 
that binding is always preceded by conversion and that it is only the converted 
material that is bound. If this concept were correct, bound C'3 should closely 
resemble converted C'3 in the fluid phase. By physicochemical and immunologic 
criteria, such resemblance was, indeed, found to exist after detachment of bound 
C'3  from cell membranes by mild procedures  (19). However,  why does  C'3i 
accumulate in the fluid phase during the hemolytic reaction if converted C~3 
was capable of being bound to cells? Obviously a third molecular form of Ct3 
has to be postulated to reconcile all observations. 
Fig. 11 illustrates the proposed concept of the mechanism of C~3 binding to 
the membrane of sheep erythrocytes. When a native C'3 molecule collides with 
cell-bound CP4,2a complex it is acted upon enzymatically. Cleavage of a critical 
bond,  the nature of which  is not yet known,  results in "activation" of the 
molecule which may simply represent  a change in conformation.  In this acti- 50  rMM-UNE HEMOLYSIS 
vated form the molecule is enabled to react with acceptor groups which occur 
on the cell surface. In order to become bound, the activated molecule has to 
transfer from the C'4, 2a complex to membrane sites. Perhaps due to instability 
of its conformation, activated C'3 has a very short half-life. It tends to convert 
to C'3i, a molecular form that is stable in conformation, but unable to bind to 
cell membranes.  Under these conditions only a  small percentage of activated 
C'3 molecules are expected to be bound; the rest will be converted to C'3i. 
There are two reasons for postulating that the site of binding is different and 
spacially separated from the site of activation.  Such a  process would explain 
(a) the observed accumulation of C'3i in the fluid phase, and (b) the capacity 
c'3i 
//  ~,,°d c3 
"Activated" C'S 
C'4, 2G complex 
Native C'  3 
FIG.  11.  Postulated mechanism of C'3 binding and conversion by EAC'la,4,2a cells. 
of a single C'4,2a site to mediate the binding of several hundred C'3 molecules. 
Verification of this concept was sought subsequently through electron micro- 
scope  studies  utilizing  ferritin-conjugated  antibodies  to  C'3  and  C'4.  The 
results,  which  will  be  reported  separately  (34),  demonstrated  clearly  that 
bound  C'3  and  C'4 molecules were distributed differently and that  C'3 may 
occupy areas of the cell membrane which are completely devoid of C'4. 
Little is known regarding the chemical nature of the binding site of C'3 on 
the cell surface. At first it seemed probable that the antibody molecules which 
coat sensitized cells serve as receptors. Under appropriate conditions, C~3 and 
also C'4 establish a  firm physical union with antigen-antibody complexes (7) 
aad with the aid of C'I esterase, C'4 can bind even to unaggregated 7S -/-globu- 
lin (14). Furthermore, Leddy et al. (35), working with the human cold agglutinin 
system, found that proteins with the antigenic properties of C'3 and C'4 were It.  ~'.  MULLER-EBERHARD,  A.  P.  DALMASSO,  M.  A.  CALCOTT  ~1 
carried along with the antibody when the latter was transferred from one cell 
batch to another. Thus, there is little doubt that CP3 and Ct4 can be bound by 
~,-globulin. Nevertheless, in the present study antibody could be ruled out as 
an essential C'3-receptor.  EC'4,2a cells were as efficient in taking up Ct3 as 
EACh4,2a cells which contained 8 units of rabbit hemolysin. Thus, in analogy 
to Ct4 (14),  C~3 appears to be capable of combining directly with membrane 
constituents. That cells  containing functionally intact C~2, C~3, and CP4 can 
be prepared in vitro without using antibody may be pertinent to certain in vivo 
processes. 
In spite of its ability to convert C~3 to  C~3i, fluid phase  C~4,2a complex 
(30 b) failed to effect binding of Ct3 to cell receptors. So far, only cell-bound 
C~4,2a was found to mediate C~3 uptake. The difference between these two 
situations is the relative proximity of the complex to C~3 binding sites, the cell- 
bound complex being consistently closer to them. The failure of fluid phase 
C~4,2a to mediate the binding reaction may simply reflect a very short half- 
life of activated C~3. However,  the possibility cannot be ruled out that the 
bound complex confers a new property upon the surrounding cell surface which 
facilitates Ct3 binding. 
The quantitative data accumulated in this study have shed light on certain 
aspects of the molecular economy inherent in the hemolytic complement re- 
action. According to available data,  C~3 represents the most abundant of all 
complement components in  human  serum;  its  concentration being  approxi- 
mately 500  to 800  #g/ml  (7,  36).  Thus,  relative to other complement com- 
ponents,  there is a  large number of C~3 molecules available for the various 
reactions of which complement is capable. As demonstrated above, due to the 
activity of the C'4,2a complex, large numbers of C~3 molecules are, in fact, 
turned over and bound to cells in immune hemolysis. Are all of these molecules 
necessary to achieve lysis of a single cell? 
According to Mayer (12, 31) a single hit is sufficient to commit a cell to lysis; 
a hit being the result of a chain reaction involving all the components of com- 
plement.  Humphrey and  Dourmashkin  (37)  showed  that  hits  result  in  the 
formation of holes in the cell membrane and that there is a fairly good corre- 
spondence between the number of holes found and the number of hits predicted 
on the basis of the one-hit theory. One would expect, therefore, to find only one 
or, perhaps,  a  very few C'3 molecules bound to a  cell  (at 64% lysis), but in 
actual fact, several thousand molecules were found. Emphasis is placed on the 
observation that the degree of lysis was proportional to the number of C~3 
molecules bound, indicating that the encountered C'3 multiplicity is relevant 
to the outcome of the hemolytic reaction. Therefore, if a single hit is sufficient 
to cause lysis of a cell, then multiple C~3 sites are required for the occurrence 
of one hit. 
The number of C'3 molecules required for a certain percentage of lysis was 52  ~  rmMOLYSXS 
shown to vary inversely with the number of C'4,2a-sites per cell. The signifi- 
cance of this phenomenon is not clear.  It might indicate that  C'3 must  be 
placed into critical areas on the erythrocyte surface in order to be hemolytically 
effective and that the probability of this happening increases with the number 
of Cr4, 2a sites bound per cell. Alternatively, the phenomenon might be related 
to the postulated joint function of C'3 and the C'4,2a complex in activating 
CP5 and C%. The mechanism of activation of Ct5 and C% is presently under 
investigation. 
SIYMMARY 
During immune  hemolysis by human  complement,  C~3 (~ic-globulin)  be- 
comes physically  attached to the erythrocyte membrane. Binding of CP3 was 
found to be mediated by ce11-bound, activated CP2 and to have the char- 
acteristics  of an enzymatic reaction.  A  single  CP4,2a site  on the cell  surface 
effected  the binding of several  hundred molecules of Ct3 if the latter  was pro- 
vided in  excess.  The accumulation of  hemolyfically  inactive,  physicochemically 
altered  C~3 in  the  fluid  phase was found to  be an  inherent  feature  of  the process 
of C~3 binding. It is postulated that C~4,2a activates  C~3 for its subsequent 
reaction  with cell  membrane receptors.  Antierythrocyte antibody did not play 
an essential  role  in CP3 uptake; CP3 could be bound to erythrocyte-C~4,2a com- 
plexes  which were entirely  devoid of antibody. 
Ce11-bound C~3 proved hemolytically active,  the degree of hemolysis being 
proportional  to the  number of  C~3 molecules per ce11.  Binding of  a large  number 
of CP3 molecules per cell  was found to be a prerequisite  for the production of 
the  immune adherence phenomenon and for  immune hemolysis. 
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